Zhang ZM - Search Results

1

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1.

Jiang Y, Wu SY, Chen YL, Zhang ZM, Tao YF, Xie Y, Liao XM, Li XL, Li G, Wu D, Wang HR, Zuo R, Cao HB, Pan JJ, Yu JJ, Jia SQ, Zhang Z, Chu XR, Zhang YP, Feng CX, Wang JW, Hu SY, Li ZH, Pan J, Fang F, Lu J. Jiang Y, et al. Among authors: zhang yp, zhang z, zhang zm. Cancer Cell Int. 2021 Nov 7;21(1):598. doi: 10.1186/s12935-021-02305-z. Cancer Cell Int. 2021. PMID: 34743716 Free PMC article.

2

PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc.

Li Z, Lim SL, Tao Y, Li X, Xie Y, Yang C, Zhang Z, Jiang Y, Zhang X, Cao X, Wang H, Qian G, Wu Y, Li M, Fang F, Liu Y, Fu M, Ding X, Zhu Z, Lv H, Lu J, Xiao S, Hu S, Pan J. Li Z, et al. Front Oncol. 2020 Nov 26;10:574525. doi: 10.3389/fonc.2020.574525. eCollection 2020. Front Oncol. 2020. PMID: 33324552 Free PMC article.

3

COCH predicts survival and adjuvant TACE response in patients with HCC.

Wang C, Ding ZW, Zheng CG, Wang S, Li ZH, Zhang ZM, Pan J, Wang J, Yang C. Wang C, et al. Among authors: zhang zm. Oncol Lett. 2021 Apr;21(4):275. doi: 10.3892/ol.2021.12536. Epub 2021 Feb 10. Oncol Lett. 2021. PMID: 33732351 Free PMC article.

4

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes.

Wu S, Jiang Y, Hong Y, Chu X, Zhang Z, Tao Y, Fan Z, Bai Z, Li X, Chen Y, Li Z, Ding X, Lv H, Du X, Lim SL, Zhang Y, Huang S, Lu J, Pan J, Hu S. Wu S, et al. Cancer Cell Int. 2021 Apr 22;21(1):230. doi: 10.1186/s12935-021-01908-w. Cancer Cell Int. 2021. PMID: 33888130 Free PMC article.

5

An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities.

Qian G, Zhu L, Li G, Liu Y, Zhang Z, Pan J, Lv H. Qian G, et al. Front Immunol. 2021 Oct 11;12:742542. doi: 10.3389/fimmu.2021.742542. eCollection 2021. Front Immunol. 2021. PMID: 34707613 Free PMC article. Review.

6

MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1.

Chen YL, Zhang ZM, Li XL, Tao YF, Wu SY, Fang F, Xie Y, Liao XM, Li G, Wu D, Wang HR, Zuo R, Cao HB, Pan JJ, Yu JJ, Zhang Z, Chu XR, Zhang YP, Feng CX, Wang JW, Lu J, Hu SY, Li ZH, Pan J. Chen YL, et al. Among authors: zhang yp, zhang z, zhang zm. Oncol Lett. 2021 Dec;22(6):838. doi: 10.3892/ol.2021.13099. Epub 2021 Oct 18. Oncol Lett. 2021. PMID: 34712362 Free PMC article.

7

ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways.

Liao X, Qian X, Zhang Z, Tao Y, Li Z, Zhang Q, Liang H, Li X, Xie Y, Zhuo R, Chen Y, Jiang Y, Cao H, Niu J, Xue C, Ni J, Pan J, Cui D. Liao X, et al. Front Oncol. 2021 Oct 18;11:753119. doi: 10.3389/fonc.2021.753119. eCollection 2021. Front Oncol. 2021. PMID: 34733788 Free PMC article.

8

SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7.

Zhang ZM, Cao HB, Li ZH, Zhuo R, Tao YF, Li XL, Li G, Liao XM, Fang F, Xie Y, Wu D, Wang HR, Wang JW, Chen YL, Yu JJ, Jia SQ, Yang RD, Guo XY, Yang Y, Feng CX, Xu YY, Qian GH, Pan J. Zhang ZM, et al. Cell Death Dis. 2022 Feb 23;13(2):174. doi: 10.1038/s41419-022-04624-z. Cell Death Dis. 2022. PMID: 35197448 Free PMC article.

9

BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma.

Chen YL, Li XL, Li G, Tao YF, Zhuo R, Cao HB, Jiao WY, Li ZH, Zhu ZH, Fang F, Xie Y, Liao XM, Wu D, Wang HR, Yu JJ, Jia SQ, Yang Y, Feng CX, Yang PC, Fei XD, Wang JW, Xu YY, Qian GH, Zhang ZM, Pan J. Chen YL, et al. Among authors: zhang zm. Cell Biosci. 2022 Mar 18;12(1):33. doi: 10.1186/s13578-022-00769-8. Cell Biosci. 2022. PMID: 35303940 Free PMC article.

10

A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells.

Zhang K, Gao L, Wang J, Chu X, Zhang Z, Zhang Y, Fang F, Tao Y, Li X, Tian Y, Li Z, Sang X, Ma L, Lu L, Chen Y, Yu J, Zhuo R, Wu S, Pan J, Hu S. Zhang K, et al. Pathol Oncol Res. 2022 Jun 27;28:1610447. doi: 10.3389/pore.2022.1610447. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35832114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,059 results

Search Page